The University of Chicago Header Logo
Last Name

Search Results (61)

Click the Why column to see why an item matched the search.

Refining patient selection for CAR T-cell therapy in aggressive large B-cell lymphoma.Academic Article Why?
Bloodless chimeric antigen receptor (CAR) T-cell therapy in Jehovah's Witnesses.Academic Article Why?
Advances in CAR T-Cell Therapy for Aggressive B-NHL.Academic Article Why?
Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy.Academic Article Why?
CardioMEMS-Guided CAR T Cell Therapy for Lymphoma in a Patient With Anthracycline-Induced Cardiomyopathy.Academic Article Why?
Current Status of CAR T Cell Therapy for Leukemias.Academic Article Why?
Kline, Justin P.Person Why?
Predictors of Humoral Response to SARS-CoV-2 Vaccination after Hematopoietic Cell Transplantation and CAR T-cell Therapy.Academic Article Why?
Riedell, PeterPerson Why?
Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study.Academic Article Why?
Ciltacabtagene Autoleucel, an Anti-B-cell Maturation Antigen Chimeric Antigen Receptor T-Cell Therapy, for Relapsed/Refractory Multiple Myeloma: CARTITUDE-1 2-Year Follow-Up.Academic Article Why?
Ventricular fibrillation following autologous intramyocardial cell therapy for inherited cardiomyopathy.Academic Article Why?
Meta-analysis of stem cell therapy in chronic ischemic cardiomyopathy.Academic Article Why?
Bishop, Michael R.Person Why?
Nakamura, YusukePerson Why?
Per Page    Page  of 5last Nextnext
Search Criteria
  • CAR
  • T
  • cell therapy
Filter by Type